Back to News
Market Impact: 0.2
PetMeds CEO Transition: Jeff Willard To Succeed Leslie Campbell
Source: Nasdaq
Management & GovernanceConsumer Demand & Retail
PetMed Express (PETS), operating as PetMeds and parent of PetCareRx, appointed Jeff Willard as CEO, president and a board member, effective September 28, 2026. The announcement provides a leadership transition update but includes no financial targets, operating outlook, or strategic details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
PETS0.20
More News
- How record diesel prices will rip through the U.S. economy. Trucks and rails are only the start
- Rising oil, rates and yields brew up stagflation cocktail for markets
- Jana Partners pushes Cooper to replace CEO, weigh asset sales- WSJ
- Oil is back above $100—but economists say that number isn’t the real threat to the U.S. economy
- College grads shut out of AI-exposed majors since 2022 are ending up in retail and food service instead of the white-collar jobs they studied for
- India to impose controversial fee for UPI instant payments: Who benefits?
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Sector Analysis, Improvements on Research Data, and Performance Enhancements
- Choosing an AI Copilot for Equity Research